Merck & Co Inc (NYSE:MRK)
$ 129.55 -0.83 (-0.64%) Market Cap: 328.13 Bil Enterprise Value: 358.83 Bil PE Ratio: 143.94 PB Ratio: 8.13 GF Score: 85/100

Q2 2021 Merck & Co Inc Earnings Call Transcript

Jul 29, 2021 / 12:00PM GMT
Release Date Price: $76.93 (-1.79%)
Operator

Good morning. My name is Mary Sara, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co Second Quarter 2021 Conference Call. (Operator Instructions) Thank you. I would now like to turn the call over to Peter Dannenbaum, VP, Investor Relations. Please go ahead.

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thank you, Mary, and good morning. Welcome to Merck's Second Quarter 2021 Conference Call. With me today are Rob Davis, our Chief Executive Officer; Dr. Dean Li, President of Merck Research Labs; Frank Clyburn, President of Human Health; and Caroline Litchfield, Chief Financial Officer.

Before we get started, I'd like to point to a few items. You will see that we have items in our GAAP results such as acquisition-related charges, restructuring costs and certain other items. You should note that we have excluded these from our non-GAAP results and provided a reconciliation in our press release. I would like to remind you that some of the statements that we make during today's call may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot